|
US4880635B1
(en)
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
ATE68968T1
(de)
*
|
1985-11-22 |
1991-11-15 |
Takeda Chemical Industries Ltd |
Liposomzusammensetzung.
|
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
|
US7625697B2
(en)
|
1994-06-17 |
2009-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for constructing subarrays and subarrays made thereby
|
|
AU3559695A
(en)
*
|
1994-09-30 |
1996-04-26 |
Inex Pharmaceuticals Corp. |
Glycosylated protein-liposome conjugates and methods for their preparation
|
|
ATE246920T1
(de)
*
|
1994-10-03 |
2003-08-15 |
Infectio Recherche Inc |
Liposomenzubereitungen zur behandlung von viruserkrankungen
|
|
US5858397A
(en)
*
|
1995-10-11 |
1999-01-12 |
University Of British Columbia |
Liposomal formulations of mitoxantrone
|
|
AU723081B2
(en)
*
|
1996-05-09 |
2000-08-17 |
Infectio Recherche Inc. |
Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
|
|
US20040072722A1
(en)
|
2002-10-10 |
2004-04-15 |
Kornblith Paul L. |
Methods for assessing efficacy of chemotherapeutic agents
|
|
AU1656799A
(en)
|
1997-12-12 |
1999-07-05 |
Inex Pharmaceuticals Corp. |
Cationic drugs encapsulated in anionic liposomes
|
|
EP1137945A1
(en)
|
1998-12-08 |
2001-10-04 |
Board of Regents, The University of Texas System |
Methods for detection of antiestrogen-resistant breast cancer
|
|
AU2055300A
(en)
|
1998-12-18 |
2000-07-03 |
Scios Inc. |
Methods for detection and use of differentially expressed genes in disease states
|
|
US6647341B1
(en)
|
1999-04-09 |
2003-11-11 |
Whitehead Institute For Biomedical Research |
Methods for classifying samples and ascertaining previously unknown classes
|
|
US7324926B2
(en)
|
1999-04-09 |
2008-01-29 |
Whitehead Institute For Biomedical Research |
Methods for predicting chemosensitivity or chemoresistance
|
|
US6911306B1
(en)
|
1999-10-18 |
2005-06-28 |
Emory University |
TMS1 compositions and methods of use
|
|
EP1484332A3
(en)
*
|
2000-02-10 |
2009-01-21 |
Liplasome Pharma A/S |
Lipid-based drug delivery system for administration of a drug substance
|
|
DK1272160T3
(da)
|
2000-04-12 |
2007-05-21 |
Liplasome Pharma As |
Lipidbaseret lægemiddelleveringssystem til topisk applikation
|
|
US20030026831A1
(en)
*
|
2001-04-20 |
2003-02-06 |
Aparna Lakkaraju |
Anionic liposomes for delivery of bioactive agents
|
|
EP1432403B1
(en)
*
|
2001-10-03 |
2010-07-28 |
Celator Pharmaceuticals, Inc. |
Liposome loading with metal ions
|
|
CA2383259A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Celator Technologies Inc. |
Synergistic compositions
|
|
US20050118250A1
(en)
*
|
2001-11-13 |
2005-06-02 |
Paul Tardi |
Lipid carrier compositions with enhanced blood stability
|
|
DE60222580T2
(de)
*
|
2001-11-13 |
2008-06-12 |
Celator Pharmaceuticals, Inc. |
Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
|
|
US8722331B2
(en)
|
2002-03-28 |
2014-05-13 |
University Of Toledo |
Method for selecting a treatment for non-small cell lung cancer using gene expression profiles
|
|
US7273620B1
(en)
|
2002-05-20 |
2007-09-25 |
University Of British Columbia |
Triggered release of liposomal drugs following mixing of cationic and anionic liposomes
|
|
US20040018525A1
(en)
|
2002-05-21 |
2004-01-29 |
Bayer Aktiengesellschaft |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma
|
|
US20040022842A1
(en)
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
DE60335469D1
(de)
*
|
2002-07-02 |
2011-02-03 |
Univ Texas |
Radioaktiv markierte verbindungen und liposome und ihre herstellungs- und anwendungsverfahren
|
|
EP1643971A2
(en)
|
2003-05-22 |
2006-04-12 |
Neopharm, Inc. |
Liposomal formulations comprising a combination of two or more active agents
|
|
WO2005014856A1
(en)
|
2003-08-08 |
2005-02-17 |
Canbas Co., Ltd. |
Sensitivity test to predict efficacy of anti-cancer therapies
|
|
EP1547674A1
(en)
*
|
2003-12-23 |
2005-06-29 |
MediGene Oncology GmbH |
Method for producing colloidal nanoparticles
|
|
US20050147978A1
(en)
|
2003-12-30 |
2005-07-07 |
Jose Remacle |
Method for quantitative determination of multi-drug resistance in tumors
|
|
JP4682152B2
(ja)
|
2003-12-31 |
2011-05-11 |
ザ・ペン・ステート・リサーチ・ファンデーション |
卵巣がんの化学療法に対する抵抗性を予測および克服するための方法ならびに結腸がんの発生を予測するための方法
|
|
EP1713938A2
(en)
|
2004-02-09 |
2006-10-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
EP1723259A2
(en)
|
2004-03-12 |
2006-11-22 |
The Queens University of Belfast |
Cancer treatment and assays for determiming resistance to platinum-based chemotherapeutic agent
|
|
CA2561835A1
(en)
|
2004-03-30 |
2005-10-13 |
Den Kgl. Veterinaer-Og Landbohojskole |
Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
|
|
CA2563074C
(en)
|
2004-04-09 |
2014-05-20 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
KR101462825B1
(ko)
|
2004-05-03 |
2014-11-21 |
헤르메스 바이오사이언스, 인코포레이티드 |
약물 전달에 유용한 리포좀
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
US20070286898A1
(en)
*
|
2004-08-31 |
2007-12-13 |
Astellas Pharma Inc. |
Intracellular Drug Delivery Improving Liposome
|
|
JP2008518886A
(ja)
|
2004-11-03 |
2008-06-05 |
リプラサム ファーマ アー/エス |
非天然ホスホリパーゼa2分解性脂質誘導体を含有する脂質ベースの薬剤送達系およびその治療的使用
|
|
US20060121511A1
(en)
|
2004-11-30 |
2006-06-08 |
Hyerim Lee |
Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
|
|
US20070172844A1
(en)
|
2005-09-28 |
2007-07-26 |
University Of South Florida |
Individualized cancer treatments
|
|
EP1951239A2
(en)
*
|
2005-10-25 |
2008-08-06 |
Celator Pharmaceuticals, Inc. |
Fixed ratio drug combination treatments for solid tumors
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
WO2007072225A2
(en)
|
2005-12-01 |
2007-06-28 |
Medical Prognosis Institute |
Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
WO2008048342A2
(en)
|
2006-02-08 |
2008-04-24 |
Dharmacon, Inc. |
Microarray for detecting and quantifying microrna
|
|
WO2007107161A2
(en)
|
2006-03-23 |
2007-09-27 |
Liplasome Pharma A/S |
Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
|
|
US20090239223A1
(en)
|
2006-07-13 |
2009-09-24 |
Siemens Healthcare Diagnostics Inc. |
Prediction of Breast Cancer Response to Taxane-Based Chemotherapy
|
|
CN101557801B
(zh)
|
2006-07-14 |
2013-10-30 |
Fmc生物聚合物联合股份有限公司 |
含有低分子量藻酸盐的水凝胶和从其制备的生物构建物
|
|
US20080076134A1
(en)
|
2006-09-21 |
2008-03-27 |
Nuclea Biomarkers, Llc |
Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
|
|
EP2094870A4
(en)
|
2006-11-03 |
2010-05-05 |
Univ Texas |
BIFUNCTIONAL PREDICTORS OF SENSITIVITY AND RESISTANCE TO CANCER THERAPY
|
|
EP2136911A2
(en)
|
2007-01-19 |
2009-12-30 |
Biodot, Inc. |
Systems and methods for high speed array printing and hybridization
|
|
WO2008112283A2
(en)
|
2007-03-12 |
2008-09-18 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
|
|
WO2008138578A2
(en)
|
2007-05-11 |
2008-11-20 |
Medical Prognosis Institute |
Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
US8361714B2
(en)
|
2007-09-14 |
2013-01-29 |
Asuragen, Inc. |
Micrornas differentially expressed in cervical cancer and uses thereof
|
|
WO2009038779A2
(en)
*
|
2007-09-19 |
2009-03-26 |
University Of Tennessee Research Foundation |
Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents
|
|
WO2009052512A2
(en)
|
2007-10-19 |
2009-04-23 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose and predict inflammatory bowel disease
|
|
WO2009080437A1
(en)
|
2007-12-21 |
2009-07-02 |
Exiqon A/S |
Micro-rna based drug resistance analysis method
|
|
EP2123258A1
(en)
*
|
2008-05-23 |
2009-11-25 |
Liplasome Pharma A/S |
Liposomes for drug delivery
|
|
CN102002490A
(zh)
|
2009-08-31 |
2011-04-06 |
上海市肿瘤研究所 |
9个用于预测原发性肝癌是否复发的microRNA标志物
|
|
DK177532B1
(en)
|
2009-09-17 |
2013-09-08 |
Bio Bedst Aps |
Medical use of sPLA2 hydrolysable liposomes
|
|
DK177529B1
(en)
|
2009-10-23 |
2013-09-08 |
Bio Bedst Aps |
Liposomes with improved storage stability
|
|
EP4350001A3
(en)
|
2009-11-23 |
2024-06-19 |
Genomic Health, Inc. |
Methods to predict clinical outcome of cancer
|
|
US20120302626A1
(en)
|
2009-12-04 |
2012-11-29 |
Sandeep Dave |
Microrna and use thereof in identification of b cell malignancies
|
|
EP2531619A4
(en)
|
2010-02-05 |
2013-08-21 |
Myriad Genetics Inc |
SIGNATURES OF THE GENE ASSOCIATED WITH HYPOXIA FOR THE CLASSIFICATION OF CANCER
|
|
WO2011098578A2
(en)
|
2010-02-12 |
2011-08-18 |
Bioneer A/S |
Liposome system for ocular administration
|
|
US20130059015A1
(en)
|
2010-03-11 |
2013-03-07 |
H. Lee Moffitt Cancer Center & Research Institute |
Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
|
|
EP2563936B1
(en)
|
2010-04-29 |
2018-03-14 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy
|
|
WO2012024543A1
(en)
|
2010-08-18 |
2012-02-23 |
Caris Life Sciences Luxembourg Holdings |
Circulating biomarkers for disease
|
|
US20120046186A1
(en)
|
2010-08-20 |
2012-02-23 |
Pelham Robert J |
Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
|
|
AU2012211964A1
(en)
|
2011-02-04 |
2013-08-22 |
Bioarray Genetics, Inc. |
Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
|
|
WO2012109233A2
(en)
|
2011-02-07 |
2012-08-16 |
Board Of Regents, The University Of Texas System |
Methods for predicting recurrence risk in breast cancer patients
|
|
EP2714927B1
(en)
|
2011-06-01 |
2016-08-10 |
Medical Prognosis Institute A/S |
Methods and devices for prognosis of cancer relapse
|
|
WO2013040393A2
(en)
|
2011-09-14 |
2013-03-21 |
Georgetown University |
Genes contributing to survival of cancer cells
|
|
WO2013130465A2
(en)
|
2012-02-27 |
2013-09-06 |
Genomic Health, Inc. |
Gene expression markers for prediction of efficacy of platinum-based chemotherapy drugs
|
|
US9606123B2
(en)
|
2013-03-29 |
2017-03-28 |
University Of Virginia Patent Foundation |
Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment
|
|
RU2528247C2
(ru)
|
2013-05-07 |
2014-09-10 |
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) |
Способ оценки чувствительности клеток рака легкого к доксорубицину на основании уровней экспрессии маркерных генов и набор для его осуществления
|
|
WO2014195032A1
(en)
|
2013-06-07 |
2014-12-11 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
|
|
US10570457B2
(en)
|
2014-09-26 |
2020-02-25 |
Medical Prognosis Institute A/S |
Methods for predicting drug responsiveness
|
|
US20160199399A1
(en)
|
2015-01-09 |
2016-07-14 |
Medical Prognosis Institute A/S |
Methods for predicting drug responsiveness in cancer patients
|
|
US20180087113A1
(en)
|
2016-09-27 |
2018-03-29 |
Oncology Venture ApS |
Methods for predicting drug responsiveness in cancer patients
|
|
US9725769B1
(en)
|
2016-10-07 |
2017-08-08 |
Oncology Venture ApS |
Methods for predicting drug responsiveness in cancer patients
|
|
AU2017258901A1
(en)
|
2016-12-30 |
2018-07-19 |
Allarity Therapeutics Europe ApS |
Methods for predicting drug responsiveness in cancer patients
|